Rna Diagnostics

About

Rna Diagnostics is a Canadian company with a patented platform technology providing real-time cancer therapy guidance.

Toronto,Ontario,Canada
11 - 50
http://rnadiagnostics.com

Highlights

Details

Last Funding Type: Angel
Last Funding Money Raised: $0.92M
Industries: Health Care,Health Diagnostics,Medical
Founded date: Jan 1, 2010
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Rna Diagnostics Inc.

Rna Diagnostics is an early-stage molecular diagnostics company developing medical diagnostic tools to assist in the management of cancer. The company's first product, the RNA Disruption AssayTM (RDATM), is a novel test that helps oncologists rapidly assess the effectiveness of cancer chemotherapy.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$1.72M $5M

Rna Diagnostics has raised a total of $1.72M $5M in funding over 2 rounds. Their latest funding was raised on Jul 26, 2019 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 26, 2019	Series A	—	1	—	—	Detail
Nov 9, 2018	Series A	$5M	1	iGan Partners	—	Detail
Jan 15, 2016	Angel	—	3	—	—	Detail
Sep 21, 2015	Angel	$800K	—	—	—	Detail
Mar 27, 2012	Angel	$0.92M	7	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

11

Rna Diagnostics is funded by 11 investors. iGan Partners and MEDTEQ+ are the most recent investors.

Investor Name	Lead Investor	Funding Round
iGan Partners	Yes	Series A
MEDTEQ+	—	Series A
Northern Ontario Angels	—	Angel
Ontario Centres of Excellence	—	Angel
York Angels Investors	—	Angel
Niagara Angel Network	—	Angel
Natacor Inc.	—	Angel
Angel One Network	—	Angel
Anges Quebec	—	Angel
Georgian Angel Network	—	Angel